Management of acute rhinosinusitis, bronchitis syndromes, and acute otitis media

Advanced Studies in Medicine

Volumn 5, Issue 7, 2005, Pages 344-350

  Jain, Sanjay K ^a   Tunkel, David E ^a   Bishai, William R ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAMASE INHIBITOR; BRONCHODILATING AGENT; CEFDINIR; CEFIXIME; CEFPODOXIME; CEFPROZIL; CEFTIBUTEN; CEFTRIAXONE; CEFUROXIME; CLARITHROMYCIN; CORTICOSTEROID; GATIFLOXACIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACUTE RESPIRATORY TRACT DISEASE; ANTIMICROBIAL THERAPY; BREAST FEEDING; BRONCHITIS; DRUG COST; DRUG INDICATION; HAEMOPHILUS INFLUENZAE; HEALTH CARE COST; HUMAN; MORAXELLA CATARRHALIS; OTITIS MEDIA; PRACTICE GUIDELINE; REVIEW; RHINOSINUSITIS; RISK FACTOR; SMOKING; STREPTOCOCCUS PNEUMONIAE;

EID: 23944499793     PISSN: 15303004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S. The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large U.S. employers in 1999. J Occup Environ Med. 2003;45:5-14.
2. International Rhinosinusitis Advisory Board. Infectious rhinosinusitis in adults: classification, etiology and management. Ear Nose Throat J. 1997;76:1-22.
3. Grossman RF. Guidelines for the treatment of acute exacerbations of chronic bronchitis. Chest. 1997;112:310S-313S.
4. Petty T. A new national strategy for COPD. J Respir Dis. 1997;18:365-369.
5. Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 summary. Adv Data, 2002:1-32.
6. McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA. 2002;287:3096-3102.
7. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA. 1995;273:214-219.
8. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis. 2001;33:757-762.
9. Bondy J, Berman S, Glazner J, Lezotte D. Direct expenditures related to otitis media diagnoses: extrapolations from a pediatric Medicaid cohort. Pediatrics. 2000;105:E72.
10. Dowell SF, Marcy SM, Phillips WR, Gerber MA, Schwartz B. Otitis media-principles of judicious use of antimicrobial agents. Pediatrics. 1998;101:165-171.
11. Rosenstein N, Phillips WR, Gerber MA, Marcy SM, Schwartz B, Dowell SF. The common cold-principles or judicious use of antimicrobial agents. Pediatrics. 1998;101:181-184.
12. O'Brien KL, Dowell SF, Schwartz B, Marcy SM, Phillips WR, Gerber MA. Acute sinusitis-principles of judicious use of antimicrobial agents. Pediatrics. 1998;101:174-177.
13. O'Brien KL, Dowell SF, Schwartz B, Marcy SM, Phillips WR, Gerber MA. Cough illness/bronchitis-principles of judicious use of antimicrobial agents. Pediatrics. 1998;101:178-181.
14. Schwartz B, Marcy SM, Phillips WR, Gerber MA, Dowell SF. Pharyngitis-principles of judicious use of antimicrobial agents. Pediatrics. 1998;101:171-174.
15. Watson RL, Dowell SF, Jayaraman M, Keyserling H, Kolczak M, Schwartz B. Antimicrobial use for pediatric upper respiratory infections: reported practice, actual practice, and parent beliefs. Pediatrics. 1999;104:1251-1257.
16. Fireman P. Diagnosis of sinusitis in children: emphasis on the history and physical examination. J Allergy Clin Immunol 1992;90:433-436.
17. Aitken M, Taylor JA. Prevalence of clinical sinusitis in young children followed up by primary care pediatricians. Arch Pediatr Adolesc Med. 1998;152:244-248.
18. Ueda D, Yoto Y. The ten-day mark as a practical diagnostic approach for acute paranasal sinusitis in children. Pediatr Infect Dis J. 1996;15:576-579.
19. Wald ER, Guerra N, Byers C. Upper respiratory tract infections in young children: duration of and frequency of complications. Pediatrics. 1991;87:129-133.
20. Williams JW Jr, Simel DL. Does this patient have sinusitis? Diagnosing acute sinusitis by history and physical examination. JAMA. 1993;270:1242-1246.
21. Otten FW, Grote JJ. The diagnostic value of transillumination for maxillary sinusitis in children. Int J Pediatr Otorhinolaryngol. 1989;18:9-11.
22. Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg. 2000;123:5-31.
23. Clinical practice guideline: management of sinusitis. Pediatrics. 2001;108:798-808.
24. Kovatch AL, Wald ER, Ledesma-Medina J, Chiponis DM, Bedingfield B. Maxillary sinus radiographs in children with nonrespiratory complaints. Pediatrics. 1984;73:306-308.
25. Gwaltney JM Jr. Acute community-acquired sinusitis. Clin Infect Dis. 1996;23:1209-1223; quiz 1224-1205.
26. Wald ER. Sinusitis. Pediatr Ann. 1998;27:811-818.
27. Guthrie R. Community-acquired lower respiratory tract infections: etiology and treatment. Chest. 2001;120:2021-2034.
28. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106:196-204.
29. Allegra L, Blosi F, de Bernardi B, Cosentini R, Tarsia P. Antibiotic treatment and baseline severity of disease in acute exacerbations of chronic bronchitis: a re-evaluation of previously published data of a placebo-controlled randomized study. Pulm Pharmacol Ther. 2001;14:149-155.
30. Nouira S, Marghli S, Belghith M, Besbes L, Elatrous S, Abroug F. Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial. Lancet. 2001;358:2020-2025.
31. Saint S, Bent S, Vittinghoff E, Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. JAMA. 1995;273:957-960.
32. Niemela M, Uhari M, Jounio-Ervasti K, Luotonen J, Alho OP, Vierimaa E. Lack of specific symptomatology in children with acute otitis media. Pediatr Infect Dis J. 1994;13:765-768.
33. Diagnosis and management of acute otitis media. Pediatrics. 2004;113:1451-1465.
34. Pelton SI. Otoscopy for the diagnosis of atitis media. Pediatr Infect Dis J. 1998;17:540-543; discussion 580.
35. Karma PH, Penttila MA, Sipila MM, Kataja MJ. Otoscopic diagnosis of middle ear effusion in acute and non-acute otitis media. I. The value of different otoscopic findings. Int J Pediatr Otorhinolaryngol. 1989;17:37-49.
36. Chonmaitree T. Viral and bacterial interaction in acute otitis media. Pediatr Infect Dis J. 2000;19:524-30.
37. Pichichero ME, Poole MD. Comparison of performance by atolaryngologists, pediatricians, and general practioners on an otoendoscopic diagnostic video examination. Int J Pediatr Otorhinolaryngol. 2005;69:361-366.
38. Wald ER. Microbiology of acute and chronic sinusitis in children and adults. Am J Med Sci. 1998;316:13-20.
39. Ball P. Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest. 1995;108:435-525.
40. Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance - a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J. 1999;18:1-9.
41. McCormick AW, Whitney CG, Farley MM, et al. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med. 2003;9:424-430.
42. Doern GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother. 2001;45:1721-1729.
43. Doern GV, Brueggemann AB, Pierce G, Holley HP Jr, Rauch A. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob Agents Chemother. 1997;41:292-297.
44. Doern GV, Jones RN, Pfaller MA, Kugler K. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob Agents Chemother. 1999;43:385-389.
45. Howie VM, Ploussard JH. The "in vivo sensitivity test"-bacteriology of middle ear exudate, during antimicrobial therapy in otitis media. Pediatrics. 1969;44:940-944.
46. Block SL, Harrison CJ, Hedrick JA, et al. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J. 1995;14:751-759.
47. Rodvold KA, Gotfried MH, Danziger LH, Servi RJ. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. Antimicrob Agents Chemother. 1997;41:1399-1402.
48. Dandekar PK, Nicolau DP. Pharmacodynamic considerations for the selection of oral cephalosporins in the treatment of rhinosinusitis. Otolaryngol Head Neck Sutg. 2002;127:510-516.
49. Steele RW, Thomas MP, Begue RE. Compliance issues related to the selection of antibiotic suspensions for children. Pediatr Infect Dis J. 2001;20:1-5.
50. Anon JB, Jacobs MR, Paale MD, et al. Antimicrobial treatment guidelines far acute bacterial rhinosinusitis. Otolaryngal Head Neck Surg. 2004;130:1-45
51. Duncan B, Ey J, Holberg CJ, Wright AL, Martinez FD, Taussig LM. Exclusive breast-feeding for at least 4 months protects against otitis media. Pediatrics. 1993;91:867-872.
52. Brown CE, Magnusan B. On the physics of the infant feeding bottle and middle ear sequela: ear disease in infants can be associated with bottle feeding. Int J Pediatr Otorhinolaryngol. 2000;54:13-20.
53. Niemela M, Pihakari O, Pokka T, Uhari M. Pacifier as a risk factor for acute otitis media: A randomized, controlled trial of parental counseling. Pediatrics. 2000;106:483-488
54. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403-409.
55. Spector SL, Bernstein IL, Li JT, et al. Parameters for the diagnosis and management of sinusitis. J Allergy Clin Immunol. 1998;102:5107-144.
56. Perrin JM, Charney E, MacWhinney JE Jr, McInerny TK, Miller RL, Nazarian LF. Sulfisoxazole as chemoprophylaxis for recurrent otitis media. A double-blind crossover study in pediatric practice. N Engl J Med. 1974;291:664-667.
57. Casselbrant ML, Kaleida PH, Rockette HE, et al. Efficacy of antimicrobial prophylaxis and of tympanostomy tube insertion for prevention of recurrent acute otitis media: results of a randomized clinical trial. Pediatr Infect Dis J. 1992;11:278-286.
58. Wilson SA, Mayo H, Fisher M. Clinical inquiries. Are tympanostomy tubes indicated for recurrent acute otitis media? J Fam Pract. 2003;52:403-404, 406.